Raymond James Financial’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-729,615
Closed -$11.1M 5334
2025
Q4
$11.1M Sell
729,615
-1,648
-0.2% -$24.5K ﹤0.01% 1874
2025
Q3
$10.9M Sell
731,263
-1,154
-0.2% -$16.7K ﹤0.01% 1853
2025
Q2
$10.5M Sell
732,417
-18,936
-3% -$263K ﹤0.01% 1829
2025
Q1
$10.9M Buy
751,353
+6,110
+0.8% +$92K ﹤0.01% 1748
2024
Q4
$11.2M Buy
+745,243
New +$11.3M ﹤0.01% 1763

Other funds holding DIAX

Raymond James Financial's DIAX Position: Q1 2026 in Review

Raymond James Financial sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 729,615 shares — an estimated $11.1M sold.

Raymond James Financial first reported a position in DIAX in Q4 2024 and held it in 5 quarters. The position peaked at $11.2M in Q4 2024. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • Raymond James Financial reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • Raymond James Financial sold 729,615 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $11.1M.
  • Raymond James Financial first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2024 and held it in 5 quarters.
  • Raymond James Financial's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $11.2M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.